ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Mainz BioMed NV

Mainz BioMed NV (MYNZ)

4,96
-1,72
(-25,75%)
Geschlossen 24 Dezember 10:00PM
4,98
0,02
(0,40%)
Nach Börsenschluss: 1:14AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
4,98
Gebot
4,95
Fragen
5,55
Volumen
188.884
4,91 Tagesbereich 6,76
3,65 52-Wochen-Bereich 49,60
Marktkapitalisierung
Handelsende
6,68
Handelsbeginn
6,60
Letzte Trade
2
@
5.17
Letzter Handelszeitpunkt
Finanzvolumen
US$ 1.031.598
VWAP
5,4615
Durchschnittliches Volumen (3 Mio.)
3.174.005
Ausgegebene Aktien
2.000.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
895k
Nettogewinn
-26,3M

Über Mainz BioMed NV

Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. It's main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results. Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. It's main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.

Sektor
Testing Laboratories
Branche
Testing Laboratories
Hauptsitz
Amsterdam, North Holland, Nld
Gegründet
-
Mainz BioMed NV is listed in the Testing Laboratories sector of the NASDAQ with ticker MYNZ. The last closing price for Mainz BioMed NV was US$6,68. Over the last year, Mainz BioMed NV shares have traded in a share price range of US$ 3,65 to US$ 49,60.

Mainz BioMed NV currently has 2.000.000 shares in issue. The market capitalisation of Mainz BioMed NV is US$13,36 million.

MYNZ Neueste Nachrichten

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

BERKELEY, Calif. and MAINZ, Germany, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in...

Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering

BERKELEY, Calif. and MAINZ, Germany, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in...

Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced at-the-Market Under Nasdaq Rules

BERKELEY, Calif. and MAINZ, Germany, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in...

Silexion Is Addressing the MOST COMMON Human Cancer Gene Mutation With RNAi; Recent M&As in the Field Were for Tens of Billions - $SLXN

December 11, 2024 -- InvestorsHub NewsWire -- via PESG Research -- The field of precision oncology has witnessed groundbreaking advancements in recent years, and Silexion Therapeutics (NASDAQ:...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.37-6.915887850475.357.22313.652656315.6457659CS
4-3.32-408.310.5563.6515057568.6172544CS
12-5.208-51.118963486510.18816.043.65317400510.34548839CS
26-13.06-72.394678492218.0422.3963.65239086211.82511962CS
52-43.22-89.668049792548.249.63.65128397812.98541754CS
156-405.02-98.785365853741012003.6551403184.00909894CS
260-569.02-99.132404181257412003.6550684593.02491841CS

MYNZ - Frequently Asked Questions (FAQ)

What is the current Mainz BioMed NV share price?
The current share price of Mainz BioMed NV is US$ 4,98
How many Mainz BioMed NV shares are in issue?
Mainz BioMed NV has 2.000.000 shares in issue
What is the market cap of Mainz BioMed NV?
The market capitalisation of Mainz BioMed NV is USD 13,36M
What is the 1 year trading range for Mainz BioMed NV share price?
Mainz BioMed NV has traded in the range of US$ 3,65 to US$ 49,60 during the past year
What is the reporting currency for Mainz BioMed NV?
Mainz BioMed NV reports financial results in USD
What is the latest annual turnover for Mainz BioMed NV?
The latest annual turnover of Mainz BioMed NV is USD 895k
What is the latest annual profit for Mainz BioMed NV?
The latest annual profit of Mainz BioMed NV is USD -26,3M
What is the registered address of Mainz BioMed NV?
The registered address for Mainz BioMed NV is KEIZERSGRACHT 391A, AMSTERDAM, NORTH HOLLAND
What is the Mainz BioMed NV website address?
The website address for Mainz BioMed NV is www.mainzbiomed.com
Which industry sector does Mainz BioMed NV operate in?
Mainz BioMed NV operates in the TESTING LABORATORIES sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DRCTDirect Digital Holdings Inc
US$ 5,25
(854,55%)
68,54M
CHEKCheck Cap Ltd
US$ 2,24
(279,66%)
40,03M
SLGLSol Gel Technologies Ltd
US$ 1,57
(265,97%)
18,2M
RELIReliance Global Group Inc
US$ 3,08
(156,67%)
105,56M
TRAWTraws Pharma Inc
US$ 12,50
(149,00%)
28,23M
AILEiLearningEngines Inc
US$ 0,199
(-77,51%)
29,69M
MGOLMGO Global Inc
US$ 0,4765
(-49,84%)
14,08M
YHCLQR House Inc
US$ 1,11
(-36,57%)
1,28M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,4014
(-34,37%)
192,3M
ADGMAdagio Medical Holdings Inc
US$ 1,095
(-33,64%)
4,84M
EDBLEdible Garden AG Inc
US$ 0,3669
(54,35%)
408,02M
RGTIRigetti Computing Inc
US$ 10,945
(16,81%)
223,51M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,4014
(-34,37%)
192,3M
NVDANVIDIA Corporation
US$ 139,67
(3,69%)
174,65M
RIMEAlgorhythm Holdings Inc
US$ 0,0925
(21,07%)
155,8M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock